EX-10.1



 Exhibit 10.1 

CONATUS PHARMACEUTICALS INC. 

STOCK PURCHASE AGREEMENT 

This STOCK PURCHASE AGREEMENT (this “Agreement”) is dated as of May 10, 2017 by and among Conatus Pharmaceuticals
Inc., a Delaware corporation (the “Company”), and the stockholders of the Company listed on Schedule I to this Agreement (each a “Holder” and collectively, the
“Holders”). 
 Background 

A. The Holders own an aggregate of 2,166,836 shares of the Company’s common stock, $0.0001 par value per share (“Common
Stock”), and have agreed to transfer, assign, sell, and convey such shares to the Company on the terms and conditions set forth in this Agreement; 

B. The Company is commencing, on or about the date hereof, an underwritten public offering (the “Public Offering”) of
certain shares of Common Stock of the Company (the “Underwritten Shares”); 
 C. The Company has proposed to use a
portion of the net proceeds from the Public Offering to repurchase 2,166,836 shares of Common Stock (the “Repurchase Shares”) from the Holders, as set forth on Schedule I, at the price per share paid by the
Underwriters to the Company in the Public Offering (the “Purchase Price”) and upon the terms and conditions provided in this Agreement (the “Repurchase”); and 

D. The Holders and the Company desire to condition the Repurchase on the closing of the Public Offering. 

NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and agreements set forth herein, the parties hereto
agree as follows: 
 Agreement 

1. Repurchase. 
 (a) Each
Holder hereby agrees, severally and not jointly, to transfer, assign, sell, and convey 100% of its right, title, and interest in and to the number of Repurchase Shares set forth opposite such Holder’s name on Schedule I hereto, and the
Company hereby agrees to purchase from each Holder, the Repurchase Shares at a price per share equal to the Purchase Price. Notwithstanding any other provision of this Agreement to the contrary, if the Purchase Price is less than $5.17, the Holders
may determine that the Purchase Price is not acceptable to the Holders in which event the Holders shall notify the Company on the pricing call that the Holders do not intend to sell the Repurchase Shares to the Company at the Closing (as defined
below). If the Holders do object to the Purchase Price, then neither the Holders nor the Company will have any further obligations to the other under this Agreement. 

(b) The obligations of the Company to purchase the Repurchase Shares shall be subject to and conditioned upon the closing of the Public
Offering pursuant to an underwriting agreement by and among the Company and the underwriters named therein (the “Underwriting Agreement”). 

(c) Subject to satisfaction or waiver of the conditions set forth herein, the closing of the sale of the Repurchase Shares (the
“Closing”) to the Company shall take place immediately following 







 
the closing of the sale of the Underwritten Shares, at the offices of Latham & Watkins LLP, 99 Bishopsgate, London EC2M 3XF, UK, or at such other time and place as may be agreed upon by
the Company and Holders (the “Closing Date”). At the Closing, each Holder shall deliver to the Company or as instructed by the Company duly executed stock powers relating to those Repurchase Shares being sold by such Holder,
and the Company agrees to deliver to each Holder by wire transfer in accordance with written instructions to be provided by the Holders prior to the Closing of immediately available funds equal to the Purchase Price multiplied by the number of
Repurchase Shares being sold by such Holder. 
 (d) The Holders each agree to pay all stamp, stock transfer and similar duties, if any, in
connection with the Repurchase. 
 (e) At the Closing, the certificates representing the Repurchase Shares will be cancelled and the Company
will retire the Repurchase Shares. 
 2. Representations and Warrants of the Company. 

The Company hereby represents and warrants to each Holder as follows: 

(a) Existence and Power. The Company has been duly organized and is validly existing and in good standing as a corporation under the
laws of the State of Delaware, with the requisite corporate power and authority to execute and deliver this Agreement and consummate the transactions and perform each of its obligations hereunder. 

(b) Authority; Enforceability. The execution and delivery of this Agreement by the Company and the consummation by the Company of each
of the transactions and the performance by the Company of each of its obligations contemplated hereby have been duly and properly authorized by all necessary corporate action on the part of the Company; and this Agreement has been duly executed and
delivered by the Company and constitutes the valid and legally binding obligation of the Company, enforceable against it in accordance with its terms, subject, as to enforceability, to bankruptcy, insolvency, reorganization, moratorium and other
similar laws of general applicability relating to or affecting creditors’ rights and to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

(c) No Conflicts. The compliance by the Company with this Agreement and the consummation of the transactions herein contemplated will
not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company is a party
or by which the Company is bound or to which any of the property or assets of the Company is subject, or (ii) violate any provision of the certificate of incorporation or by-laws, as applicable, of the
Company, except, in the case of clause (i), as would not reasonably be expected to have a material adverse effect on the financial position, stockholders’ equity or results of operations of the Company, taken as a whole (a “Material
Adverse Effect”), in the case of each such clause, after giving effect to any consents, approvals, authorizations, orders, registrations, qualifications, waivers and amendments as will have been obtained or made as of the date of this
Agreement; and no consent, approval, authorization, order, registration or qualification of or with any such court or governmental agency or body is required for the execution, delivery and performance by the Company of its obligations under this
Agreement, including the consummation by the Company of the transactions contemplated by this Agreement, except where the failure to obtain or make any such consent, approval, authorization, order, registration or qualification would not reasonably
be expected to have a Material Adverse Effect. 
 3. Representations and Warrants of the Holders. 







 Each Holder represents and warrants to the Company as follows: 

(a) Existence and Power. Each Holder has been duly organized and is validly existing and in good standing under the laws of its
jurisdiction of formation or organization, with the requisite power and authority to execute and deliver this Agreement and consummate the transactions and perform each of its obligations contemplated hereunder. 

(b) Authority; Enforceability. The execution and delivery of this Agreement by the Holder and the consummation by the Holder of each of
the transactions and the performance by the Holder of each of its obligations contemplated hereby have been duly and properly authorized by all necessary action on the part of the Holder. This Agreement has been duly executed and delivered by the
Holder and constitutes the valid and legally binding obligation of such Holder, enforceable against such Holder in accordance with its terms, subject, as to enforceability, to bankruptcy, insolvency, reorganization, moratorium and other similar laws
of general applicability relating to or affecting creditors’ rights and to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

(c) No Conflicts. The sale of the Repurchase Shares to be sold by such Holder hereunder and the compliance by such Holder with all of
the provisions of this Agreement and the consummation of the transactions contemplated herein (i) will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any statute,
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which such Holder is a party or by which such Holder is bound or to which any of the property or assets of such Holder is subject, (ii) nor will such action
result in any violation of the provisions of (a) any organizational or similar documents pursuant to which such Holder was formed or (b) any statute or any order, rule or regulation of any court or governmental agency or body having
jurisdiction over such Holder or the property of such Holder; except in the case of clause (i) or clause (ii)(b), for such conflicts, breaches, violations or defaults as would not impair in any material respect the consummation of such
Holder’s obligations hereunder. 
 (d) Ownership of Common Stock. As of the date hereof and immediately prior to the delivery of
the Repurchase Shares to the Company at the Closing, such Holder will be the record and beneficial owner of the Repurchase Shares set forth opposite such Holder’s name on Schedule I to this Agreement with full
dispositive power thereover, and holds, and will hold, such Repurchase Shares free and clear of all mortgages, pledges, security interests, liens, claims, encumbrances, equities or other restrictions (collectively, the
“Liens”). Upon payment for the Repurchase Shares to be sold by such Holder in accordance with the terms and conditions of this Agreement, the Company will acquire good and valid title to such shares free and clear all Liens.

 (e) Independent Investigation. Each Holders has received all of the information that it considers necessary or appropriate for
deciding whether to sell the Repurchase Shares and have had the opportunity to ask questions and receive answers from the Company. Each Holder has the requisite knowledge, sophistication and experience in order to fairly evaluate a disposition of
the Repurchase Shares to be sold by such Holder hereunder, including the risks associated therewith. 
 4. Conditions to Closing.

 (a) Conditions to Obligations of the Company. The obligation of the Company to purchase the Repurchase Shares hereunder is subject
to the satisfaction or waiver on or prior to the Closing Date of each the following conditions: 
 i. No action, claim, suit, hearing,
complaint, demand, injunction, litigation, judgment, arbitration, order, decree, ruling or governmental investigation or proceeding shall be pending 







 
or threatened by any Governmental Entity, and no such Governmental Entity shall have issued any injunction, judgment or order, which shall remain in effect, that would prevent the consummation of
the transactions contemplated hereby. As used herein, the term “Governmental Entity” means any agency, bureau, commission, authority, department, official, political subdivision, tribunal or other instrumentality of any
government, whether (i) regulatory, administrative or otherwise; (ii) federal, state or local or (iii) domestic or foreign. 

ii. The representations and warranties of each Holder contained in this Agreement and in any other writing delivered by each Holder pursuant
hereto shall be true and correct in all material respects on and as of the date hereof and on and as of the Closing Date, as applicable, as though made on and as of such date. 

iii. The Company and the Underwriters shall have entered into the Underwriting Agreement providing for the sale by the Company of at least
5,166,836 shares of Common Stock. 
 (b) Conditions to Obligations of Holders. The obligation of each Holder to sell the Repurchase
Shares hereunder is subject to the satisfaction or waiver on or prior to the Closing Date of each the following conditions: 
 i. No action,
claim, suit, hearing, complaint, demand, injunction, litigation, judgment, arbitration, order, decree, ruling or governmental investigation or proceeding shall be pending or threatened by any Governmental Entity, and no such Governmental Entity
shall have issued any injunction, judgment or order, which shall remain in effect, that would prevent the consummation of the transactions contemplated hereby. 

ii. The Company shall have performed in all material respects all of its obligations hereunder required to be performed by it on or prior to
the Closing Date. 
 iii. The representations and warranties of the Company contained in this Agreement shall be true and correct in all
material respects on and as of the date hereof and on and as of the Closing, as though made on and as of such date. 
 5. Governmental
Filings. Each Holder shall make all filings with any Governmental Entity required by such Holder in connection with the execution and delivery by such Holder of this Agreement and the consummation by such Holder of the transactions contemplated
hereby, including without limitation, all filings with the Securities and Exchange Commission required pursuant to the Securities Exchange Act of 1934, as amended. 

6. General Provisions. 

(a) Amendments and Waivers. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in
writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by any party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. 

(b) Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and
their respective successors and assigns. 
 (c) Governing Law. This Agreement shall be governed by and construed in accordance with
the law of the State of New York, without reference to its conflict of laws principles. 







 (d) Section Headings. The captions and headings appearing at the
beginning of the various sections of this Agreement are for convenience of reference only and shall not be given any effect whatsoever in the construction or interpretation of this Agreement. 

(e) Enforcement. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were
not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms
and provisions of this Agreement in any action instituted in any court of the United States or any state thereof having jurisdiction over the parties and the matter, this being in addition to any other remedy to which they are entitled at law or in
equity. 
 (f) Severability. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as
to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms
or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as is enforceable. 

(g) Termination. 
 i. This
Agreement may be terminated with respect to any Holder at any time by the mutual written consent of the Company and such Investor. 
 ii.
Notwithstanding any provision in this Agreement to the contrary, this Agreement shall terminate (A) in the event the Underwriting Agreement is terminated; (B) at such time as the Holders notify the Company on the pricing call in connection
with the Public Offering pursuant to Section 1(a) above that they do not intend to sell the Repurchase Shares to the Company at the Closing; or (C) if the Underwriting Agreement has not been executed and delivered by the parties thereto
on or before May 31, 2017. 
 iii. If this Agreement is terminated, the Company will have no obligation to purchase the Repurchase
Shares and the Holders will have no obligation to sell the Repurchase Shares hereunder, and no party will have any further obligation hereunder. 

(h) Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. Any party may execute this Agreement by the delivery of a facsimile signature, which signature shall have the same force and effect as an original signature. Any party that delivers a
facsimile signature shall promptly thereafter deliver an originally executed signature to the other party; provided, however, that the failure to deliver an original signature page shall not affect the validity of any signature delivered by
facsimile. 
 [Signature Page Follows] 







 IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed by its
duly authorized officer as of the date first written above. 
  

			
	COMPANY:
	
	CONATUS PHARMACEUTICALS INC.
		
	By:	 	 /s/ Steven J. Mento, Ph.D.

	Name: Steven J. Mento, Ph.D.
	Title: President and Chief Executive Officer









 IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed by its
duly authorized officer as of the date first written above. 
  

			
	HOLDERS:
	
	ADVENT PRIVATE EQUITY FUND III ‘A’
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT PRIVATE EQUITY FUND III ‘B’
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT PRIVATE EQUITY FUND III ‘C’
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT PRIVATE EQUITY FUND III ‘D’
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT PRIVATE EQUITY FUND III GMBH & CO KG
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT PRIVATE EQUITY FUND III AFFILIATES









			
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT MANAGEMENT III LIMITED PARTNERSHIP
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT PRIVATE EQUITY FUND IV
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner
	
	ADVENT MANAGEMENT IV LIMITED PARTNERSHIP
		
	By:	 	 /s/ Shahzad Malik

	Name: Shahzad Malik
	Title: General Partner








 Schedule I 

to Stock Purchase Agreement 
  

					
	 Holder
	  	Number of
Repurchase
Shares	 
	 Advent Private Equity Fund III ‘A’
	  	 	772,216	 
	 Advent Private Equity Fund III ‘B’
	  	 	378,389	 
	 Advent Private Equity Fund III ‘C’
	  	 	105,549	 
	 Advent Private Equity Fund III ‘D’
	  	 	207,614	 
	 Advent Private Equity Fund III GmbH & Co KG
	  	 	29,871	 
	 Advent Private Equity Fund III Affiliates
	  	 	24,891	 
	 Advent Management III Limited Partnership
	  	 	7,465	 
	 Advent Private Equity Fund IV
	  	 	634,500	 
	 Advent Management IV Limited Partnership
	  	 	6,341	 
		  	  
	  
	 
	 Total:
	  	 	2,166,836